Oxford Biomedica Management

Management criteria checks 1/4

Oxford Biomedica's CEO is Frank Mathias, appointed in Mar 2023, has a tenure of 1.08 years. directly owns 0.02% of the company’s shares, worth £44.00K. The average tenure of the management team and the board of directors is 1.4 years and 3.8 years respectively.

Key information

Frank Mathias

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.1yrs
CEO ownership0.02%
Management average tenure1.4yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oct 19
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Aug 23
Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 15
Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Oct 06
Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

May 02
Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

Jun 29
We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

We Think Oxford Biomedica (LON:OXB) Can Easily Afford To Drive Business Growth

Mar 09
We Think Oxford Biomedica (LON:OXB) Can Easily Afford To Drive Business Growth

What Kind Of Shareholders Own Oxford Biomedica plc (LON:OXB)?

Feb 08
What Kind Of Shareholders Own Oxford Biomedica plc (LON:OXB)?

Investors Who Bought Oxford Biomedica (LON:OXB) Shares Five Years Ago Are Now Up 202%

Dec 24
Investors Who Bought Oxford Biomedica (LON:OXB) Shares Five Years Ago Are Now Up 202%

The Independent Non-Executive Director of Oxford Biomedica plc (LON:OXB), Andrew John Heath, Just Sold 79% Of Their Holding

Dec 02
The Independent Non-Executive Director of Oxford Biomedica plc (LON:OXB), Andrew John Heath, Just Sold 79% Of Their Holding

Oxford Biomedica (LON:OXB) Is In A Good Position To Deliver On Growth Plans

Dec 01
Oxford Biomedica (LON:OXB) Is In A Good Position To Deliver On Growth Plans

CEO

Frank Mathias (61 yo)

1.1yrs

Tenure

Dr. Frank Mathias is Chief Executive Officer and Director of Oxford Biomedica plc from March 27, 2023. Dr. Mathias was the Chief Executive Officer of Rentschler Biopharma SE from April 2016 until March 202...


Leadership Team

NamePositionTenureCompensationOwnership
Stuart Paynter
CFO & Director6.7yrsUK£888.00k0.019%
£ 41.1k
Frank Mathias
CEO & Director1.1yrsno data0.020%
£ 44.0k
Thierry Cournez
COO & Oxford Site Headless than a yearno datano data
James Miskin
Chief Quality & Technical Officerno datano data0.14%
£ 312.6k
Matthew Treagus
Chief Information Officer2.7yrsno data0.0097%
£ 21.4k
Sophia Bolhassan
Head of Investor Relationsno datano datano data
Natalie Walter
General Counsel & Company Secretary4.9yrsno datano data
Lisa James
Chief People Officer2yrsno datano data
Kyriacos Mitrophanous
Chief Innovation Officerless than a yearno datano data
Kati Hudson
Head of Intellectual Property and Contractsno datano datano data
Sebastien Ribault
Chief Commercial Officer1.4yrsno datano data
Mark Caswell
Site Head of US Operationsless than a yearno datano data

1.4yrs

Average Tenure

51yo

Average Age

Experienced Management: OXB's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Stuart Paynter
CFO & Director6.7yrsUK£888.00k0.019%
£ 41.1k
Frank Mathias
CEO & Director1.1yrsno data0.020%
£ 44.0k
Michael Hayden
Non-Independent Non-Executive Director2.8yrsUK£130.00k0.040%
£ 87.9k
Frederic Doliveux
Non-Executive Chair3.8yrsUK£1.16m0.37%
£ 818.0k
William Langston
Member of Scientific Advisory Boardno datano datano data
Peter Stern
Member of Scientific Advisory Boardno datano datano data
Krystof Bankiewicz
Member of Scientific Advisory Boardno datano datano data
Heather Preston
Independent Non-Executive Director6.1yrsUK£140.00k0.018%
£ 40.3k
Dame Davies
Senior Independent Director3.1yrsUK£65.00k0.0010%
£ 2.2k
Catherine Moukheibir
Independent Non-Executive Director2.3yrsUK£140.00k0.026%
£ 56.7k
Stuart Henderson
Independent Vice Chair7.8yrsUK£85.00k0.011%
£ 23.9k
Robert Ghenchev
Non-Executive Director4.8yrsno datano data

3.8yrs

Average Tenure

64yo

Average Age

Experienced Board: OXB's board of directors are considered experienced (3.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.